Literature DB >> 9627647

Long-term postoperative results of a consecutive series of stages 4 and 5 retinopathy of prematurity.

M T Trese1, P J Droste.   

Abstract

OBJECTIVE: The purpose of the study was to assess the long-term, anatomic, and functional results of a consecutive series of stages 4 and 5 retinopathy of prematurity (ROP) eyes after surgical management.
DESIGN: A retrospective analysis of 42 eyes of 21 children yielded 34 eyes of 19 children who were operated on for stages 4 and 5 ROP. PARTICIPANTS: In 33 of 34 eyes, it was possible to have age-appropriate vision testing. The children were followed for a mean of 44 months.
RESULTS: Seventy-six percent of eyes (25 of 33) in which vision testing was possible had partial or complete attachment of the posterior pole. Fifteen percent of all eyes achieved 20/300 or better visual acuity. Thirty percent of all eyes achieved 20/800 or better visual acuity. Forty-eight percent of eyes achieved ambulatory vision of 20/ 1900 visual acuity or better, and 72% of eyes achieved light perception or better vision. All eyes were managed similarly for their preoperative screening, surgical therapy, and postoperative refractive correction by one vitreoretinal surgeon and one pediatric ophthalmologist.
CONCLUSION: Timely surgical intervention and appropriate postoperative care can result in useful vision in stages 4 and 5 ROP.

Entities:  

Mesh:

Year:  1998        PMID: 9627647     DOI: 10.1016/S0161-6420(98)96024-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

1.  Minimally fibrotic stage 5 ROP: a clinical prognostic factor in eyes undergoing vitrectomy for stage 5 retinopathy of prematurity.

Authors:  Salil S Gadkari; Madan Deshpande; Sucheta Kulkarni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-10-27       Impact factor: 3.117

2.  Vision development over an extended follow-up period in babies after successful vitrectomy for stage 4b retinopathy of prematurity.

Authors:  Salil Gadkari; Rushita Kamdar; Sucheta Kulkarni; Madan Deshpande; Sudhir Taras
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-31       Impact factor: 3.117

3.  Anesthesia protocols for early vitrectomy in former preterm infants diagnosed with aggressive posterior retinopathy of prematurity.

Authors:  Kazuyoshi Aoyama; Youichi Kondou; Yasuyuki Suzuki; Hirokazu Sakai; Masayuki Oshima; Eiichi Inada
Journal:  J Anesth       Date:  2010-08       Impact factor: 2.078

4.  Outcome of eyes developing retinal detachment during the Early Treatment for Retinopathy of Prematurity study.

Authors:  Michael X Repka; Betty Tung; William V Good; Antonio Capone; Michael J Shapiro
Journal:  Arch Ophthalmol       Date:  2011-09

Review 5.  Paediatric retinal detachment: a review.

Authors:  Raffaele Nuzzi; Carlo Lavia; Roberta Spinetta
Journal:  Int J Ophthalmol       Date:  2017-10-18       Impact factor: 1.779

6.  Lens-sparing vitrectomy for stage 4 and stage 5 retinopathy of prematurity.

Authors:  Young Suk Yu; Seong-Joon Kim; So Young Kim; Ho Kyung Choung; Gyu Hyung Park; Jang Won Heo
Journal:  Korean J Ophthalmol       Date:  2006-06

7.  Long-term results of lens-sparing vitrectomy for stages 4B and 5 retinopathy of prematurity.

Authors:  Jin Choi; Jeong Hun Kim; Seong-Joon Kim; Young Suk Yu
Journal:  Korean J Ophthalmol       Date:  2011-09-20

8.  Immediate Sequential Bilateral Vitrectomy Surgery for Retinopathy of Prematurity: A Single Surgeon Experience

Authors:  Şengül Özdek; Mehmet Cüneyt Özmen; Duygu Yalınbaş; Hatice Tuba Atalay; Demet Coşkun
Journal:  Turk J Ophthalmol       Date:  2021-08-27

9.  Functional and anatomical outcomes after primary lens-sparing pars plana vitrectomy for Stage 4 retinopathy of prematurity.

Authors:  Pramod Bhende; Lingam Gopal; Tarun Sharma; Aditya Verma; Rupak Kanti Biswas
Journal:  Indian J Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 1.848

10.  Surgical management in advanced stages of retinopathy of prematurity; our experience.

Authors:  Ramak Roohipoor; Reza Karkhaneh; Mohammad Riazi-Esfahani; Fariba Ghasemi; Mehdi Nili-Ahmadabadi
Journal:  J Ophthalmic Vis Res       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.